These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 31612411)

  • 1. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.
    Pitsillou E; Bresnehan SM; Kagarakis EA; Wijoyo SJ; Liang J; Hung A; Karagiannis TC
    Mol Biol Rep; 2020 Jan; 47(1):753-770. PubMed ID: 31612411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of Oxidative Stress, Neuroinflammation and Abnormal Myelination in Excessive Aggression Associated with Depression: Recent Input from Mechanistic Studies.
    Gorlova A; Svirin E; Pavlov D; Cespuglio R; Proshin A; Schroeter CA; Lesch KP; Strekalova T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting inflammatory pathways for treatment of the major depressive disorder.
    Patil CR; Suryakant Gawli C; Bhatt S
    Drug Discov Today; 2023 Sep; 28(9):103697. PubMed ID: 37422168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide: Antidepressant mechanisms and inflammation.
    Ghasemi M
    Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.
    Millard SJ; Weston-Green K; Newell KA
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109908. PubMed ID: 32145362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting inflammation: a potential approach for the treatment of depression.
    Bhatt S; Devadoss T; Jha NK; Baidya M; Gupta G; Chellappan DK; Singh SK; Dua K
    Metab Brain Dis; 2023 Jan; 38(1):45-59. PubMed ID: 36239867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping up with the clinical advances: depression.
    Ragguett RM; Tamura JK; McIntyre RS
    CNS Spectr; 2019 Aug; 24(S1):25-37. PubMed ID: 31248466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants.
    Martín-Hernández D; Caso JR; Javier Meana J; Callado LF; Madrigal JLM; García-Bueno B; Leza JC
    J Neuroinflammation; 2018 Sep; 15(1):251. PubMed ID: 30180869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA System in Depression: Impact on Pathophysiology and Psychopharmacology.
    Della Vecchia A; Arone A; Piccinni A; Mucci F; Marazziti D
    Curr Med Chem; 2022; 29(36):5710-5730. PubMed ID: 34781862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical Exercise and Neuroinflammation in Major Depressive Disorder.
    Ignácio ZM; da Silva RS; Plissari ME; Quevedo J; Réus GZ
    Mol Neurobiol; 2019 Dec; 56(12):8323-8335. PubMed ID: 31228000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways of major depressive disorder converge on the synapse.
    Fries GR; Saldana VA; Finnstein J; Rein T
    Mol Psychiatry; 2023 Jan; 28(1):284-297. PubMed ID: 36203007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular network of neuronal autophagy in the pathophysiology and treatment of depression.
    Jia J; Le W
    Neurosci Bull; 2015 Aug; 31(4):427-34. PubMed ID: 26254058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and major depression.
    Dhir A; Kulkarni SK
    Nitric Oxide; 2011 Apr; 24(3):125-31. PubMed ID: 21335097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.
    Fakhoury M
    Mol Neurobiol; 2016 Jul; 53(5):2778-2786. PubMed ID: 25823514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of depression: an overview of the current science.
    Elder BL; Mosack V
    Issues Ment Health Nurs; 2011; 32(4):192-202. PubMed ID: 21355753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythms and treatment implications in depression.
    Monteleone P; Martiadis V; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1569-74. PubMed ID: 20691746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimmunology of depression.
    Sarno E; Moeser AJ; Robison AJ
    Adv Pharmacol; 2021; 91():259-292. PubMed ID: 34099111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of cannabidiol in depression.
    Guldager MB; Chaves Filho AM; Biojone C; Joca S
    Int Rev Neurobiol; 2024; 177():251-293. PubMed ID: 39029987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.